The ASCO Post Podcast
By BroadcastMed
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by BroadcastMed
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 7
Reviews: 0
Episodes: 182
Description
News and views from the world of clinical oncology and hematology.
| Episode | Date |
|---|---|
|
IASLC WCLC 2020: Research in Mesothelioma, Small Cell Lung Cancer, and Drug Development
|
Jul 12, 2023 |
|
IASLC WCLC 2020: Updates From the ADAURA Trial and More
|
Jul 12, 2023 |
|
Prevalence of KRAS G12C Mutations Across Different Populations
|
Jul 12, 2023 |
|
More From GI21: Findings in Gastric Cancer, Cholangiocarcinoma, and Pancreatic Cancer
|
Jul 12, 2023 |
|
Findings From the 2021 Gastrointestinal Cancers Symposium
|
Jul 12, 2023 |
|
IDEA Collaboration: 3 vs 6 Months of Adjuvant Chemotherapy for Patients With Advanced Colon Cancer
|
Jul 12, 2023 |
|
News From the 2020 San Antonio Breast Cancer Symposium
|
Jul 12, 2023 |
|
More News From ASH: Whole-Genome Sequencing of Myeloproliferative Neoplasms and More
|
Jul 12, 2023 |
|
News From the 2020 ASH Annual Meeting & Exposition
|
Jul 12, 2023 |
|
COVID-19: Infection Rate Among Patients Undergoing Anticancer Therapy and Its Effect on Cancer Clinical Trials
|
Jul 12, 2023 |
|
Immune-Related Adverse Events and Survival Outcomes in NSCLC
|
Jul 12, 2023 |
|
Prostate Cancer Highlights From the 2020 ASTRO Annual Meeting
|
Jul 12, 2023 |
|
2020 ASTRO Annual Meeting: High-Impact Research
|
Jul 12, 2023 |
|
Recent FDA Approvals in Leukemia and Lymphoma
|
Jul 12, 2023 |
|
First-Line Atezolizumab vs Chemotherapy for PD-L1–Positive Metastatic NSCLC
|
Jul 12, 2023 |
|
Breast Cancer News From the ESMO Virtual Congress 2020
|
Jul 12, 2023 |
|
Lung Cancer Reports From the ESMO Virtual Congress 2020
|
Jul 12, 2023 |
|
ESMO Virtual Congress 2020: Spotlight on Genitourinary Cancers
|
Jul 12, 2023 |
|
ESMO Virtual Congress 2020: Findings in Breast and Head and Neck Cancers
|
Jul 12, 2023 |
|
Veliparib Plus Carboplatin/Paclitaxel in BRCA-Mutated, HER2-Negative Advanced Breast Cancer
|
Jul 12, 2023 |
|
From the Archive: Insights on Young-Onset Colorectal Cancer
|
Jul 12, 2023 |
|
Highlights From the IASLC Virtual Presidential Symposium
|
Jul 12, 2023 |
|
Decline in Non–Small Cell Lung Cancer Mortality From 2013 to 2016
|
Jul 12, 2023 |
|
Pathologic Complete Response in the I-SPY2 Trial
|
Jul 12, 2023 |
|
New Guidelines on Cervical Cancer Screening
|
Jul 12, 2023 |
|
Comparison of Two Combination Treatments in Localized Pancreatic Cancer
|
Jul 12, 2023 |
|
Cabozantinib for Patients With Advanced Bladder Cancer
|
Jul 12, 2023 |
|
Lenvatinib Plus Pembrolizumab for Patients With Advanced Gastric Cancer
|
Jul 12, 2023 |
|
Spotlight on Two Breast Cancer Studies From the ASCO20 Virtual Scientific Program
|
Jul 12, 2023 |
|
Multiple Myeloma Research From the ASCO20 Virtual Scientific Program
|
Jul 12, 2023 |
|
COVID-19 Research From the ASCO20 Virtual Scientific Program
|
Jul 12, 2023 |
|
Findings in Prostate Cancer From the ASCO20 Virtual Scientific Program
|
Jul 12, 2023 |
|
Plenary Research From the ASCO20 Virtual Scientific Program: Part 2
|
Jul 12, 2023 |
|
Plenary Research From the ASCO20 Virtual Scientific Program: Part 1
|
Jul 12, 2023 |
|
Coagulation Issues in Patients With COVID-19: Part 2
|
Jul 11, 2023 |
|
Coagulation Issues in Patients With COVID-19: Part 1
|
Jul 11, 2023 |
|
Highlights From the AACR Virtual Annual Meeting
|
Jul 11, 2023 |
|
Does Ibrutinib Offer a Protective Effect Against Pulmonary Injury in Patients With COVID-19?
|
Jul 11, 2023 |
|
Recent FDA Oncology/Hematology Approvals
|
Jul 11, 2023 |
|
Characteristics and Outcomes of Patients With Both COVID-19 and Cancer
|
Jul 11, 2023 |
|
Report on the ASH COVID-19 Registry for Malignant Hematology
|
Jul 11, 2023 |
|
End-of-Trial Findings From CLEOPATRA
|
Jul 11, 2023 |
|
Cancer Care Amid the COVID-19 Pandemic
|
Jul 11, 2023 |
|
Coronavirus, Patients With Cancer, and the Preparedness of the Institutions That Care for Them
|
Jul 11, 2023 |
|
Pulmonary Pathology of the Novel Coronavirus in Two Patients With Lung Cancer
|
Jul 11, 2023 |
|
News From the 2020 Multidisciplinary Head and Neck Cancers Symposium
|
Jul 11, 2023 |
|
News From the Genitourinary Cancers Symposium
|
Jul 11, 2023 |
|
Pembrolizumab Plus Chemotherapy in HER2-Negative Breast Cancer
|
Jul 11, 2023 |
|
H. pylori Infection and Gastric Cancer Risk
|
Jul 11, 2023 |
|
BEACON CRC: Patient-Reported Quality of Life Results
|
Jul 11, 2023 |
|
News From the Gastrointestinal Cancers Symposium
|
Jul 11, 2023 |
|
Elevations in Cancer Incidence Among Responders to the WTC Site After the September 11 Attacks
|
Jul 11, 2023 |
|
Impact of Time of Day of Immune Checkpoint Inhibitor Infusion on Overall Survival in Advanced Melanoma
|
Jul 11, 2023 |
|
Recent Approvals From the FDA
|
Jul 10, 2023 |
|
News From the San Antonio Breast Cancer Symposium
|
Jul 10, 2023 |
|
Plenary Presentations From the 2019 ASH Annual Meeting & Exposition
|
Jul 10, 2023 |
|
Sequence of Therapies for Metastatic Castration-Resistant Prostate Cancer
|
Jul 10, 2023 |
|
Reports From the ESMO Asia Congress 2019
|
Jul 10, 2023 |
|
Nivolumab Plus Bevacizumab for Relapsed Ovarian Cancer
|
Jul 10, 2023 |
|
ADMIRAL Trial of Gilteritinib vs Salvage Chemotherapy in FLT3-Mutated Acute Myeloid Leukemia
|
Jul 10, 2023 |
|
Addition of Durvalumab to Etoposide Plus Platinum Chemotherapy for Extensive-Stage SCLC
|
Jul 10, 2023 |
|
Gastrointestinal Cancer Research From ESMO 2019
|
Jul 10, 2023 |
|
News in Genitourinary Cancers From ESMO 2019
|
Jul 10, 2023 |
|
Selected Breast Cancer Abstracts From ESMO 2019
|
Jul 10, 2023 |
|
Lung Cancer Research Highlights From ESMO 2019
|
Jul 10, 2023 |
|
News in Ovarian Cancer From ESMO 2019
|
Jul 10, 2023 |
|
Benefit of Daratumumab Across Populations With Newly Diagnosed Multiple Myeloma
|
Jul 10, 2023 |
|
News From the ASTRO Annual Meeting
|
Jul 10, 2023 |
|
News From the IASLC World Conference on Lung Cancer and the ASCO Quality Care Symposium
|
Jul 10, 2023 |
|
First-Line Nivolumab and Ipilimumab vs Sunitinib in Advanced Renal Cell Carcinoma
|
Jul 10, 2023 |
|
Pooled Survival Analysis of Patients With NSCLC Treated With Nivolumab
|
Jul 10, 2023 |
|
USPSTF Recommendation Against Pancreatic Cancer Screening in Asymptomatic Adults
|
Jul 10, 2023 |
|
Ibrutinib and Rituximab vs Standard Chemoimmunotherapy in CLL
|
Jul 10, 2023 |
|
Erdafitinib for FGFR-Altered Advanced Urothelial Carcinoma
|
Jul 10, 2023 |
|
Overall Survival in MONALEESA-7
|
Jul 07, 2023 |
|
Rates of Early-Onset Colorectal Cancer
|
Jul 07, 2023 |
|
Long-Term Results From the National Lung Screening Trial
|
Jul 07, 2023 |
|
ESMO World GI: Findings From the BEACON CRC Trial and More
|
Jul 07, 2023 |
|
ICML 2019: Role of Liquid Biopsy in Lymphoma
|
Jul 07, 2023 |
|
CASSIOPEIA Trial in Multiple Myeloma
|
Jul 07, 2023 |
|
2019 ASCO: Resection of Liver Metastases
|
Jul 07, 2023 |
|
2019 ASCO: Pancreatic, Urothelial, and Cervical Cancers
|
Jul 05, 2023 |
|
Updates in the Surgical Management of Breast Cancer
|
May 05, 2023 |
|
More From the AACR Annual Meeting 2023: Novel Therapeutics, Immunotherapy for Liver Cancer, and More
|
Apr 28, 2023 |
|
Highlights From the AACR Annual Meeting 2023
|
Apr 21, 2023 |
|
NCCN 2023 Annual Conference: Quality of Life Issues
|
Apr 14, 2023 |
|
Highlights From the NCCN 2023 Annual Conference
|
Apr 07, 2023 |
|
RUBY Trial in Endometrial Cancer and Breast Cancer Screening After Treatment
|
Mar 31, 2023 |
|
Highlights From the SSO 2023 International Conference on Surgical Cancer Care
|
Mar 24, 2023 |
|
Colorectal Cancer Awareness Month: Spotlight on Recent Research in Gastrointestinal Oncology
|
Mar 17, 2023 |
|
2023 ASCO Genitourinary Cancers Symposium: Focus on Bladder Cancer
|
Mar 10, 2023 |
|
2023 ASCO Genitourinary Cancers Symposium: Focus on Prostate Cancer
|
Mar 03, 2023 |
|
2023 ASCO Genitourinary Cancers Symposium: Focus on RCC
|
Feb 24, 2023 |
|
Recent FDA Approvals for Patients With Breast Cancer
|
Feb 14, 2023 |
|
Highlights From the 2023 ASCO Gastrointestinal Cancers Symposium
|
Feb 03, 2023 |
|
Sotorasib in Previously Treated Patients With KRAS G12C–Mutated Advanced Pancreatic Cancer: In Conversation With The ASCO Post
|
Jan 27, 2023 |
|
2022 ASH Annual Meeting and Exposition: Focus on Lymphoma
|
Jan 20, 2023 |
|
2022 ASH Annual Meeting and Exposition: Focus on Multiple Myeloma
|
Jan 13, 2023 |
|
2022 ASH Annual Meeting and Exposition: Focus on Leukemia
|
Jan 06, 2023 |
|
Highlights From the 2022 San Antonio Breast Cancer Symposium
|
Dec 16, 2022 |
|
FDA Approvals: November 2022
|
Dec 02, 2022 |
|
Findings From SITC 2022
|
Nov 18, 2022 |
|
Recent Trial Findings in Genitourinary Oncology
|
Nov 04, 2022 |
|
FDA Approvals in Hepatocellular Carcinoma and Multiple Myeloma
|
Oct 28, 2022 |
|
Effects of Mortgage Discrimination on Cancer Care Outcomes
|
Oct 14, 2022 |
|
ESMO 2022: Updates in Skin Cancer
|
Oct 07, 2022 |
|
Highlights From the 2022 ASCO Quality Care Symposium
|
Oct 03, 2022 |
|
ESMO 2022: Updates in Breast Cancer
|
Sep 23, 2022 |
|
Highlights From the ESMO Congress 2022
|
Sep 16, 2022 |
|
FDA Approval of Pemigatinib and Update From the STAMPEDE Trial
|
Sep 02, 2022 |
|
Highlights From the European Hematology Association 2022 Congress
|
Aug 26, 2022 |
|
ASCO 2022: Conversations in Colorectal Cancer
|
Aug 19, 2022 |
|
ASCO 2022: Conversations in Leukemia
|
Aug 12, 2022 |
|
ASCO 2022: Conversations in Lung Cancer
|
Aug 02, 2022 |
|
ASCO 2022: Conversations in Breast Cancer
|
Jul 29, 2022 |
|
ASCO 2022: Conversations in Gynecologic Oncology
|
Jul 23, 2022 |
|
ASCO 2022: Conversations in Genitourinary Oncology
|
Jul 15, 2022 |
|
ASCO 2022: Research in Multiple Myeloma and Breast Cancer
|
Jul 12, 2022 |
|
ASCO 2022: Plenary Presentation in Colorectal Cancer
|
Jul 08, 2022 |
|
ASCO 2022: Data in Ewing Sarcoma and Non–Small Cell Lung Cancer
|
Jun 27, 2022 |
|
ASCO 2022: Major Studies in Breast Cancer and Mantle Cell Lymphoma
|
Jun 17, 2022 |
|
ASCO 2022: High-Impact Research in Breast and Colon Cancers
|
Jun 13, 2022 |
|
FDA Approvals in Esophageal Cancer and Follicular Lymphoma
|
Jun 02, 2022 |
|
FDA Approval for Newly Diagnosed Acute Myeloid Leukemia
|
May 27, 2022 |
|
Reports From the Society of Gynecologic Oncology Annual Meeting on Women’s Cancer
|
May 20, 2022 |
|
MONALEESA-3: Updated Overall Survival Analysis
|
May 13, 2022 |
|
FDA Approves Fam-Trastuzumab Deruxtecan-nxki for Adult Patients With Unresectable or Metastatic HER2-Positive Breast Cancer
|
May 06, 2022 |
|
More From the AACR Annual Meeting 2022: Future Research Trends
|
Apr 27, 2022 |
|
Highlights From the NCCN 2022 Annual Conference
|
Apr 04, 2022 |
|
FDA Approvals in Prostate and Endometrial Cancers
|
Mar 29, 2022 |
|
FDA Approval in Germline BRCA-Mutated, HER2-Negative, High-Risk Early Breast Cancer
|
Mar 18, 2022 |
|
First FDA Approval for Neoadjuvant Therapy for Early-Stage Non–Small Cell Lung Cancer
|
Mar 11, 2022 |
|
Reports From the 2022 Multidisciplinary Head and Neck Cancers Symposium
|
Mar 04, 2022 |
|
More From the ASCO Genitourinary Cancers Symposium: Data on Bladder Cancer, Prostate Cancer, and Treatment Disparities
|
Mar 01, 2022 |
|
News From the 2022 ASCO Genitourinary Cancers Symposium
|
Feb 18, 2022 |
|
Efficacy of Adagrasib in Various Gastrointestinal Cancers
|
Feb 11, 2022 |
|
President Biden Relaunches the Cancer Moonshot
|
Feb 04, 2022 |
|
FDA Approval in Metastatic Uveal Melanoma
|
Jan 28, 2022 |
|
Highlighted Presentations From the 2022 ASCO Gastrointestinal Cancers Symposium
|
Jan 24, 2022 |
|
Relatlimab Plus Nivolumab Improves PFS in Patients With Previously Untreated Metastatic or Unresectable Melanoma
|
Jan 14, 2022 |
|
Apatinib for Advanced Radioactive Iodine–Refractory Differentiated Thyroid Cancer
|
Jan 07, 2022 |
|
Research From the 2021 ASH Annual Meeting & Exposition
|
Dec 17, 2021 |
|
Research From the 2021 San Antonio Breast Cancer Symposium
|
Dec 11, 2021 |
|
SITC 2021: New Data in Immunotherapy
|
Nov 19, 2021 |
|
NCCN 2021 Virtual Congress on Hematologic Malignancies: Round-up
|
Nov 10, 2021 |
|
Prostate Cancer Research From the 2021 ASTRO Annual Meeting
|
Nov 05, 2021 |
|
News From the 2021 ASTRO Annual Meeting
|
Oct 29, 2021 |
|
Oncology Care in the Ongoing COVID-19 Pandemic: Expert Commentary
|
Oct 22, 2021 |
|
FDA Approvals in Breast and Cervical Cancers
|
Oct 15, 2021 |
|
Lung Cancer Data From the ESMO Congress 2021
|
Oct 08, 2021 |
|
ESMO Congress 2021: News in Genitourinary Cancers
|
Sep 27, 2021 |
|
High-Impact Research From the ESMO Congress 2021
|
Sep 20, 2021 |
|
News From the IASLC 2021 World Conference on Lung Cancer
|
Sep 13, 2021 |
|
Withdrawal of Atezolizumab's Indication for Metastatic Triple-Negative Breast Cancer
|
Sep 03, 2021 |
|
Recent FDA Approvals: dMMR Solid Tumors and von Hippel Lindau–Associated Cancers
|
Aug 27, 2021 |
|
Breakthrough COVID-19 Infection in Vaccinated Health-Care Workers
|
Aug 23, 2021 |
|
Presentations From the 2021 Pan Pacific Lymphoma Conference
|
Aug 09, 2021 |
|
Defining Cure in Multiple Myeloma
|
Jul 31, 2021 |
|
Recommendations on the Use of Liquid Biopsy for Lung Cancer
|
Jul 23, 2021 |
|
FDA Approval in Urothelial Cancer, Plus Mechanisms of Acquired Resistance in KRAS G12C–Mutant Cancers
|
Jul 16, 2021 |
|
Five- vs 2-Year Course of Zoledronate for Patients With Early Breast Cancer
|
Jul 09, 2021 |
|
News From the EHA 2021 Virtual Congress: Multiple Myeloma, Myelofibrosis, and Leukemia
|
Jul 03, 2021 |
|
News in Genitourinary Cancers From the 2021 ASCO Annual Meeting
|
Jun 25, 2021 |
|
Lung Cancer Data From the 2021 ASCO Annual Meeting
|
Jun 18, 2021 |
|
2021 ASCO Annual Meeting: Reports on Kidney, Esophageal, and Cervical Cancers
|
Jun 11, 2021 |
|
100th Episode: Reports From the 2021 ASCO Annual Meeting in Breast, Prostate, and Lung Cancers
|
Jun 04, 2021 |
|
USPSTF Recommendation on Colorectal Cancer Screening Beginning at Age 45
|
May 28, 2021 |
|
2021 ASCO Annual Meeting: Data From a Premeeting Presscast
|
May 21, 2021 |
|
Comparison of Adjuvant Trastuzumab Courses for Early HER2-Positive Breast Cancer
|
May 14, 2021 |
|
Dr. John and Liza Marshall on Their New Book Off Our Chests: A Candid Tour Through the World of Cancer
|
May 08, 2021 |
|
Intensified Preoperative Therapy for Patients With Newly Diagnosed Locally Advanced Rectal Cancer
|
Apr 30, 2021 |
|
Short-Term Safety of the COVID-19 Vaccine in Patients With Cancer Receiving Immunotherapy
|
Apr 26, 2021 |
|
More News From the AACR Annual Meeting: Cancer Biology, Brain Metastases, and Diet
|
Apr 19, 2021 |
|
News From the AACR Annual Meeting: NSCLC, Lymphoma, and Uveal Melanoma
|
Apr 12, 2021 |
|
Differences in Disease Between Younger and Older Women With Breast Cancer
|
Apr 02, 2021 |
|
More From SGO: News in Ovarian and Cervical Cancers
|
Mar 26, 2021 |
|
News From the Society of Gynecologic Oncology’s 2021 Annual Meeting on Women’s Cancer
|
Mar 19, 2021 |
|
Increase in Breast Cancer Diagnoses After Pandemic-Related Screening Interruptions
|
Mar 12, 2021 |
|
Recent Regulatory Decisions in Multiple Myeloma and Lung Cancer
|
Mar 08, 2021 |
|
Genitourinary Cancers Symposium: Immunotherapy for RCC, Neoadjuvant Therapy for Bladder Cancer
|
Feb 25, 2021 |
|
Genitourinary Cancers Symposium: Bladder and Kidney Cancers Research
|
Feb 19, 2021 |
|
Selected Studies From the 2019 ASCO Annual Meeting
|
Jun 06, 2019 |